证券代码：002350 证券简称：北京科锐 公告编号：2025-095 第八届董事会第十八次会议决议公告 北京科锐集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 北京科锐集团股份有限公司（以下简称"公司"）第八届董事会第十八次会 议于 2025 年 12 月 29 日 10:00 以通讯方式召开，会议通知于 2025 年 12 月 25 日以 邮件及微信方式送达。本次会议应到董事 9 名，实到董事 9 名。会议由公司董事 长付小东先生主持。本次会议符合《中华人民共和国公司法》《北京科锐集团股 份有限公司章程》《董事会议事规则》的规定，会议的召集、召开合法有效。本 次董事会会议经审议通过如下决议： 北京科锐集团股份有限公司董事会 2025 年 12 月 29 日 一、审议通过《关于子公司拟合资设立海外二级控股子公司的议案》 为了开拓海外新能源领域业务布局，同意全资子公司北京科锐能源管理有限 公司以自有或自筹资金出资8万欧元与Greenova Energy Limited共同出资在爱尔兰 投资新设合资公司 Creative Energy Inve ...

北京科锐集团股份有限公司 关于第二期员工持股计划第一次持有人大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 北京科锐集团股份有限公司（以下简称"公司"）第二期员工持股计划（以下简称"本员工持股计划"）第 一次持有人大会于2025年12月18日以通讯方式召开，会议通知于2025年12月5日向全体持有人发出。本 次会议应到持有人37名，实到37名，代表本员工持股计划份额112,860,000份。会议由公司董事会秘书付 静女士主持。本次会议符合《北京科锐集团股份有限公司章程》《第二期员工持股计划管理办法》《第 二期员工持股计划（草案）》的规定，会议的召集、召开合法有效。本次会议经审议通过如下决议： 一、审议通过《关于设立公司第二期员工持股计划管理委员会的议案》 为了便于第二期员工持股计划的日常监督管理，同意本员工持股计划设管理委员会，管理委员会对员工 持股计划持有人会议负责，是员工持股计划的日常监督管理机构。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002350 证券简称：北京科锐 公告编号：2025-094 管理委员会由3名委员组 ...

证券代码：002350 证券简称：北京科锐 公告编号：2025-094 北京科锐集团股份有限公司 关于第二期员工持股计划第一次持有人大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 北京科锐集团股份有限公司（以下简称"公司"）第二期员工持股计划（以 下简称"本员工持股计划"）第一次持有人大会于 2025 年 12 月 18 日以通讯方式 召开，会议通知于 2025 年 12 月 5 日向全体持有人发出。本次会议应到持有人 37 名，实到 37 名，代表本员工持股计划份额 112,860,000 份。会议由公司董事会秘 书付静女士主持。本次会议符合《北京科锐集团股份有限公司章程》《第二期员 工持股计划管理办法》《第二期员工持股计划（草案）》的规定，会议的召集、 召开合法有效。本次会议经审议通过如下决议： 一、审议通过《关于设立公司第二期员工持股计划管理委员会的议案》 为了便于第二期员工持股计划的日常监督管理，同意本员工持股计划设管理 委员会，管理委员会对员工持股计划持有人会议负责，是员工持股计划的日常监 督管理机构。 管理委员会由 3 名委员组成，设 ...

证券日报网讯12月12日晚间，北京科锐（002350）发布公告称，截至本公告日，公司及控股子公司最近 12个月内对外担保(含对子公司担保)余额为7217.16万元(含本次担保)，占公司最近一期经审计净资产约 4.27%；公司及控股子公司对合并报表外单位提供的担保总余额为78万元，占公司最近一期经审计净资 产约0.05%，公司不存在逾期担保、涉及诉讼担保等事项。 ...

二、担保进展情况 近日，公司与上海浦东发展银行股份有限公司北京分行（以下简称"浦发银 行"）签署了《保证合同》。因经营需要，固安科锐与浦发银行于 2025 年 12 月 10 日签署了《固定资产贷款合同》，浦发银行向固安科锐提供贷款，金额为人民 币 1,360 万元。根据《保证合同》，公司为上述贷款金额以及由此产生的利息（包 括利息、罚息和复利）、违约金、损害赔偿金、手续费及其他为签订或履行本合 同而发生的费用、以及债权人实现担保权利和债权所产生的费用（包括但不限于 诉讼费、律师费、差旅费等），以及根据《固定资产贷款合同》经债权人要求债 务人需补足的保证金提供连带责任保证。 本次担保前公司对固安科锐的可用担保额度为 1,560 万元，本次担保后公司对 固安科锐可用担保额度为 200 万元。 三、担保具体情况 证券代码：002350 证券简称：北京科锐 公告编号：2025-093 北京科锐集团股份有限公司 关于为全资二级子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 北京科锐集团股份有限公司（以下简称"公司"）于 20 ...

Core Viewpoint - Beijing Keri has won multiple projects from the State Grid, with a total bid amount of 498 million yuan, accounting for 24.36% of the company's audited revenue for 2024 [1][2]. Group 1: Project Details - The projects include various procurement items such as low-voltage power cables, transformers, and integrated ring network boxes across different regions, with specific bid amounts detailed for each project [3]. - The total bid amounts for specific projects are as follows: - Northwest and Tibet regions: approximately 28.93 million yuan - Central and Southwest regions: approximately 51.15 million yuan - Northeast region: approximately 36.52 million yuan - East China region: approximately 78.83 million yuan - North China region: approximately 84.75 million yuan [3]. Group 2: Financial Performance - In the first three quarters of 2025, Beijing Keri reported a net profit attributable to shareholders of 28.99 million yuan, a year-on-year increase of 1417.63%, with a gross margin of 22.36%, up 1.94 percentage points from the previous year [6]. - The company's operating revenue for the same period was 1.438 billion yuan, reflecting a year-on-year growth of 14.16% [6]. - The significant profit increase is attributed to investment income from subsidiary disposals, reduced fair value losses, and increased government subsidies [6]. Group 3: Strategic Initiatives - Beijing Keri is actively expanding its business in renewable energy, including solar and energy storage projects, in response to the national "dual carbon" strategy [4]. - The company has also increased its R&D investment, with expenses reaching 65.18 million yuan in the first three quarters of 2025, a year-on-year increase of 28.33% [5]. - A share repurchase plan was announced, with a total amount not less than 50 million yuan and not exceeding 100 million yuan, aimed at implementing employee stock ownership plans [6]. Group 4: Market Performance - As of December 10, 2025, Beijing Keri's stock price was 9.18 yuan per share, reflecting a 5.28% increase on that day and a cumulative increase of approximately 21.6% since the beginning of the year [7].

证券日报网讯 12月10日晚间，北京科锐发布公告称，公司控股股东科锐北方及公司实际控制人、董事 长付小东先生本次减持计划实施期限已届满，减持期间内未减持公司股份。 （文章来源：证券日报） 证券日报网讯 12月10日晚间，北京科锐发布公告称，公司控股股东科锐北方及公司实际控制人、董事 长付小东先生本次减持计划实施期限已届满，减持期间内未减持公司股份。 （文章来源：证券日报） ...

Key Points - Yonghui Supermarket's stock may face significant decline risks after a short-term surge [1] - Fuzhijing Technology's actual controller reduced holdings by 1.0429 million shares during abnormal stock fluctuations [1] Investment Projects - Ninghu Expressway plans to invest 9 billion yuan in the construction of the Nanyang Yangtze River Bridge southern connection project [1] - China Shipbuilding Special Gas plans to invest approximately 870 million yuan to build an annual production facility for 3,383 tons of high-purity hydrogen sulfide and other electronic gases [1] Contract Wins - Jicheng Electronics won contracts totaling approximately 215 million yuan for multiple State Grid projects [1] - Beixin Road and Bridge secured a 180 million yuan engineering project [1] - Beijing Kerui won a 498 million yuan State Grid project [1] Equity Acquisitions - Blues Technology intends to acquire 100% of Peimei Gao International to expand into the AI computing infrastructure sector [1] - Daon Co. plans to acquire 80% of Ningbo Aisikai [1] - Alibaba Travel Investment intends to subscribe for 20% equity in Zhongxin Youyou through a 55% stake in Hangzhou Aixin [1] Share Buybacks - Xingyu Co. plans to repurchase shares with an investment of 200 million to 300 million yuan [1]

Key Points - Yonghui Supermarket (601933.SH) may face significant downside risk after a large short-term price increase [2] - Fuzhijun Technology (002222.SZ) saw its actual controller reduce holdings by 1.0429 million shares during the period of abnormal stock fluctuations [2] - Ninghu Expressway (600377.SH) plans to invest 9 billion yuan in the construction of the Nanyang Yangtze River Bridge southern approach project [2] - Jicheng Electronics (002339.SZ) won contracts totaling approximately 215 million yuan for multiple State Grid projects [2] - Lens Technology (300433.SZ) intends to acquire 100% of Peimei Gao International to expand into the AI computing infrastructure sector [2] - Xingyu Co., Ltd. (601799.SH) plans to repurchase shares with an investment of 200 million to 300 million yuan [2] - Zhuangyuan Pasture (002910.SZ) board member Ma Hongfu plans to reduce holdings by no more than 3% [2] - Ruili Kemi (001285.SZ) has received project designation from clients [3] - Guangliwei (301095.SZ) plans to establish a wholly-owned subsidiary in Singapore focused on application research and global sales [3]

Group 1 - Jicheng Electronics won a total of 15 bids from the State Grid Corporation, with a total bid amount of approximately 215 million yuan, accounting for 8.27% of the company's projected revenue for 2024 [2] - Jianmin Group's chemical generic drug, Ambrutoro Oral Solution, has been approved for market launch by the National Medical Products Administration, aimed at treating cough and wheezing caused by chronic bronchitis and emphysema [3] - Taiji Industry's subsidiary plans to transfer accounts receivable not exceeding 85 million USD to optimize cash flow, with an expected service fee of approximately 285,000 USD [4] Group 2 - Nanjing Pharmaceutical's subsidiary plans to invest 398 million yuan in a modern pharmaceutical logistics expansion project, with a construction period of approximately 35 months [5] - Ruili Kemi received a development notification from a well-known domestic flying car company to supply core components [6] - Ding Tong Technology announced that several executives plan to reduce their holdings by a total of no more than 45,300 shares, representing about 0.032% of the total share capital [7][8] Group 3 - Ninghu Expressway's subsidiary plans to invest no more than 9.033 billion yuan in the construction of the Nanyang Yangtze River Bridge South Connection Project [10] - Wuliangye announced a mid-term profit distribution plan for 2025, proposing a cash dividend of 25.78 yuan per 10 shares, totaling approximately 10 billion yuan [12] - Beixin Road and Bridge's subsidiary won a bid for a project worth 180 million yuan [14] Group 4 - Minhe Livestock reported a 7.75% month-on-month increase in sales revenue from commodity chick sales in November [15] - Xuelong Group plans to invest 100 million yuan to establish a wholly-owned subsidiary for vertical integration in the aluminum and magnesium technology sector [16] - Shengnong Development reported a 15.77% year-on-year increase in sales revenue in November, with significant growth in both poultry and processed meat products [17] Group 5 - Xingyu Co., Ltd. plans to repurchase shares worth 200 million to 300 million yuan for employee stock ownership plans [18] - Quan Chai Power intends to use 50 million yuan of idle funds to purchase structured deposit products [19] - Shibei High-tech appointed Zhao Junhong as the new deputy general manager [20] Group 6 - Fuan Pharmaceutical's subsidiary received a drug registration certificate for injectable isavuconazole, expanding its anti-infection product line [21] - Xiaoming Co. reported a 49.73% year-on-year decline in chicken product sales revenue in November [22] - Baiao Chemical adjusted its share repurchase price ceiling to no more than 48.95 yuan per share [23] Group 7 - Hefei China reported a 26.02% year-on-year decline in consolidated revenue for the first 11 months [24] - Laimei Pharmaceutical's subsidiary received medical device registration certificates for two endoscope products [25][26] - Xiantan Co. reported an 11.63% year-on-year increase in chicken product sales revenue in November [27] Group 8 - Qilin Security received government subsidies totaling 5.4014 million yuan [28] - Blue Sky Gas's controlling shareholder's 30.9134 million shares were judicially frozen, accounting for 4.33% of the total share capital [29] - Tieke Railway signed a contract for high-speed railway fasteners worth 654 million yuan, accounting for 41.08% of the company's projected revenue for 2024 [30] Group 9 - David Medical's electric surgical table received a medical device registration certificate [31] - Zhendong Pharmaceutical's affiliate's core product new drug application was accepted by the CDE [32] - Shanghai Pharmaceutical's apple acid sitagliptin tablet application for market approval was granted by the National Medical Products Administration [33] Group 10 - Nanjiao Food reported a 1.14% year-on-year increase in consolidated revenue for November [34]